Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck.

Oral oncology - 1 Jun 2018

Saloura Vassiliki, Vougiouklakis Theodore, Sievers Cem, Burkitt Kyunghee, Nakamura Yusuke, Hager Gordon, van Waes Carter

Abstract excerpt

Squamous cell carcinoma of the head and neck is a lethal disease with suboptimal survival outcomes and standard therapies with significant comorbidities. Whole exome sequencing data recently revealed an abundance of genetic and expression alterations in a family of enzymes known as protein methyltransferases in a variety of cancer types, including squamous cell carcinoma of the head and neck. These enzymes are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Head and Neck Neoplasms

Share to Methylation

Share to Mutation

Share to Protein Methyltransferases

Share to Squamous Cell Carcinoma of Head and Neck

Source

Open in PubMed Open full text

Identifiers

PMID: 29884408
DOI: 10.1016/j.oraloncology.2018.04.014
PMCID: PMC6681457

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck.PMID 29884408Read ↗

Overcoming Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma (HNSCC)—The Role of Histone Demethylase and Methyltransferase InhibitorsSemantic proximity Read ↗

Advances in the study of posttranslational modifications of histones in head and neck squamous cell carcinomaSemantic proximity Read ↗

Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targetsSemantic proximity Read ↗

Therapeutic Insights from Genomic Studies of Head and Neck Squamous Cell CarcinomasSemantic proximity Read ↗

Analysis of the Oncogenic Role of Methyltransferase Like 3 (METLL3) in Head and Neck Squamous Cell Carcinoma (HNSCC)Semantic proximity Read ↗

Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical ImplicationsSemantic proximity Read ↗

Genetic and epigenetic landscape of nasopharyngeal carcinoma.Semantic proximity Read ↗

The comprehensive analysis of the prognostic and functional role of N-terminal methyltransferases 1 in pan-cancerSemantic proximity Read ↗

Epigenetic and genetic alterations-based molecular classification of head and neck cancerSemantic proximity Read ↗

DNA Methylome Distinguishes Oropharyngeal and Oral Cancer from Oral Lesions and Healthy Oral MucosaSemantic proximity Read ↗

Exploring the role of m6A modification in cancerSemantic proximity Read ↗

A Clinically Distinct and 'Atypical' Subgroup of Head and Neck Cancers Positive for a CpG Island Methylator Phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.